Patent classifications
G01N33/571
Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
A method is presented for treating herpes simplex virus (HSV) infection comprising: (a) locally administering a substance that induces a delayed type hypersensitivity (DTH) response to a patient at a site of an HSV lesion to induce a DTH response at the site of the lesion during one or more outbreaks of the HSV infection.
COMBINATION TREPONEMAL AND NON-TREPONEMAL SYPHILIS TEST
Provided herein are multiplex assays for detecting antibodies indicative of presence and stage of syphilis infection in an individual. Individuals infected with syphilis produce antibodies directed to syphilis components and the lipid cellular debris associated with the infection. The present disclosure represents the first combination of these diverse antibody targets in a single assay.
COMBINATION TREPONEMAL AND NON-TREPONEMAL SYPHILIS TEST
Provided herein are multiplex assays for detecting antibodies indicative of presence and stage of syphilis infection in an individual. Individuals infected with syphilis produce antibodies directed to syphilis components and the lipid cellular debris associated with the infection. The present disclosure represents the first combination of these diverse antibody targets in a single assay.
Reliable and Scalable Methods of Detection and Platform for Consumer Medical Devices
The present disclosure includes multiplexed systems, methods, devices, and kits for detecting status of one or more health conditions in a single device. It includes an extraction container for receiving a sample and extracting a target material from the sample; a testing container with at least a first and second well containing one or more buffers for receiving the extracted target material, and a signal output device including a housing containing two or more strips, each strip containing a) a loading zone; b) a reaction zone; c) a testing zone; and d) a control zone. The system and methods can be adapted for assessment of sexual health of one or more subjects, in relation to pregnancy, fertility, and/or sexually transmitted infections caused by one or more agents.
Reliable and Scalable Methods of Detection and Platform for Consumer Medical Devices
The present disclosure includes multiplexed systems, methods, devices, and kits for detecting status of one or more health conditions in a single device. It includes an extraction container for receiving a sample and extracting a target material from the sample; a testing container with at least a first and second well containing one or more buffers for receiving the extracted target material, and a signal output device including a housing containing two or more strips, each strip containing a) a loading zone; b) a reaction zone; c) a testing zone; and d) a control zone. The system and methods can be adapted for assessment of sexual health of one or more subjects, in relation to pregnancy, fertility, and/or sexually transmitted infections caused by one or more agents.
Process and machine for automated agglutination assays with image automated evaluation
The machine is configured to perform an automated rapid plasma reagent (RPR) agglutination test or other agglutination test. The machine includes a sample rack with multiple sample locations thereon and a reagent rack for storing of reagent. A shaker assembly supports at least one microtiter plate or other well supporting structure thereon with a plurality of wells in the plate. An automated pipette accesses samples and reagent and deposits them within wells of the microtiter plate. The shaker assembly shakes multiple samples within the wells of the microtiter plate. Finally, a camera photographs the wells of the plate, preferably from above with a light source below and the plate at least partially transparent. The image is then analyzed in an automated fashion to determine whether a ring of contrast material has remained smooth indicative of a non-reactive sample or has agglutinated/clumped together indicative of a reactive sample.
Process and machine for automated agglutination assays with image automated evaluation
The machine is configured to perform an automated rapid plasma reagent (RPR) agglutination test or other agglutination test. The machine includes a sample rack with multiple sample locations thereon and a reagent rack for storing of reagent. A shaker assembly supports at least one microtiter plate or other well supporting structure thereon with a plurality of wells in the plate. An automated pipette accesses samples and reagent and deposits them within wells of the microtiter plate. The shaker assembly shakes multiple samples within the wells of the microtiter plate. Finally, a camera photographs the wells of the plate, preferably from above with a light source below and the plate at least partially transparent. The image is then analyzed in an automated fashion to determine whether a ring of contrast material has remained smooth indicative of a non-reactive sample or has agglutinated/clumped together indicative of a reactive sample.
HUMAN PAPILLOMA VIRUS AS PREDICTOR OF CANCER PROGNOSIS
Methods of treating a head and neck cancer are disclosed.
HUMAN PAPILLOMA VIRUS AS PREDICTOR OF CANCER PROGNOSIS
Methods of treating a head and neck cancer are disclosed.
Treponema pallidum triplet antigen
A Treponema pallidum triplet antigen construct is disclosed which includes three Treponema pallidum antigens (TP15, TP17, and TP47), as well as a ten amino acid leader sequence (tag 261) and human copper zinc superoxide dismutase (hSOD). This construct is optimized for in vitro diagnosis of syphilis infection. Plasmids containing DNA encoding the triplet antigen, host cells, production methods, detection methods, and kits are also disclosed.